SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-761726
Filing Date
2016-11-07
Accepted
2016-11-07 16:35:04
Documents
60
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d273767d10q.htm 10-Q 547682
2 EX-31.1 d273767dex311.htm EX-31.1 6753
3 EX-31.2 d273767dex312.htm EX-31.2 7013
4 EX-32.1 d273767dex321.htm EX-32.1 3177
5 EX-32.2 d273767dex322.htm EX-32.2 3242
  Complete submission text file 0001193125-16-761726.txt   4479364

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT casc-20160930.xml EX-101.INS 1013548
7 XBRL TAXONOMY EXTENSION SCHEMA casc-20160930.xsd EX-101.SCH 53348
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casc-20160930_cal.xml EX-101.CAL 31140
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casc-20160930_def.xml EX-101.DEF 355144
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE casc-20160930_lab.xml EX-101.LAB 287424
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casc-20160930_pre.xml EX-101.PRE 370603
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Filer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33882 | Film No.: 161978598
SIC: 8731 Services-Commercial Physical & Biological Research